Under a pre-emergency use authorization, Emergent BioSolutons has provided the Department of Health and Human Services with its AV7909 anthrax vaccine for emergency preparedness since 2019. Four years ...
A new day has dawned in the fight against the U.S. opioid epidemic after the FDA approved the first over-the-counter naloxone product. And the gold medal goes to Emergent BioSolutions. Wednesday, the ...
Millions of doses were lost due to quality-control issues, the probe found. Between March 2020 and February 2022, vaccine-maker Emergent BioSolutions was forced to discard or destroy up to 400 million ...
Quality control errors led millions of potential vaccines to be ruined. For Emergent BioSolutions, Feb. 8 was a day to revel in their success -- at least as far as the public was concerned. Standing ...
When contract-manufacturer Emergent BioSolutions contaminated at least 15 million doses of Johnson & Johnson’s COVID-19 vaccine and millions more doses of AstraZeneca’s vaccine at its Baltimore ...
Emergent hits $15 million in ARR in 90 days, becomes one of the fastest growing AI start-ups; its platform is the world's first agentic vibe-coding platform that builds production-ready applications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback